Hospitals trial AI to spot type 2 diabetes risk
Briefly

Dr Fu Siong Ng highlights the potential of the Aire-DM AI system to detect type 2 diabetes risk by analyzing ECG data, with an accuracy of around 70%.
The British Heart Foundation emphasizes that early detection of diabetes through AI technology could save lives, preventing complications such as heart attacks and strokes.
The trial aims to test the effectiveness of the Aire-DM system on up to 1,000 patients, combining ECG data with other risk factors for improved accuracy.
While current results are promising, it may take up to five years for the AI technology to be rolled out across the NHS for broader use.
Read at www.bbc.com
[
|
]